AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06244849 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Ileocolonic biopsies
Description: An ileo-colonoscopy with 10 ileal biopsies scheduled in their regular medical follow-up will be performed
Study NCT06160700 — intervention group
Intervention type: BEHAVIORAL
Intervention: Montreal Cognitive Assessment (MoCA)
Description: MoCA is a method for evaluating cognition. This assessment will be conducted at baseline, month 3, and month 6.
Study NCT05081154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product D
Description: P1012815, a nicotine pouch with 8 mg nicotine
Study NCT05081154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product E
Description: P1013315, a nicotine pouch with 8 mg nicotine
Study NCT05081154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product F
Description: P1013115, a nicotine pouch with 8 mg nicotine
Study NCT05788614 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Reverse shoulder arthroplasty
Description: Reverse shoulder arthroplasty
Study NCT05423795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine-based intervention
Description: Telemedicine-based intervention Multifaceted intervention including daily videoconferences with audit and feedback, educational interventions, and dissemination of published works
Study NCT05423795 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care arm
Description: Classic expertise (as routinely performed in the participating ICU)
Study NCT05645159 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blended learning in heart disease
Description: The intervention included face-to-face classes and online resources (Moodle, online syllabus, videos, websites, podcasts, activities, apps, forums, emails, tutoring).
Study NCT05081154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product G
Description: P1013215, a nicotine pouch with 8 mg nicotine
Study NCT04689867 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Suicide Prevention for psychosis CBSPp)
Description: Cognitive and behavioral approach to suicide prevention among individuals with psychosis
Study NCT04719260 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Thinking®
Description: In the first session, the nutritionist will carry out the anamnesis through the Empathy Map and assessment of the nutritional status to define the Nutrition Briefing. The steps described by Design Thinking as understanding, observation, and point of view comprise the first phase of this session. The ideation process will proceed from the definition of the Nutrition Challenge. Prototyping is the final stage of the first session, where an initial prototype of the diet will be co-created based on visual thinking tools and the description underlying the creation of diets. Within 24 hours the individual will receive a summary of the material developed by email. The period between sessions will comprise the testing phase and the follow-up sessions the iteration phase where the experience and previous steps are revisited in order to create new insights, anthropometric measurements will be seen as reflections of the experience and not as primary outcomes of the intervention.
Study NCT04719260 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Nutritional Approach
Description: In the first session the nutritionist will carry out the food and nutritional anamnesis and assessment of the nutritional status. From this information, the nutritionist will generate the diagnostic hypothesis and determine the specific nutritional needs. The professional will be responsible for generating the dietary prescription defining the characteristics of the diet that will be delivered printed to the individual after a period of 15 days, in the second session of the protocol. The follow-up session will be based on adherence to the established conduct and monitoring of anthropometric variations.
Study NCT04632511 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: MetaSAMP
Description: Rectal Sampler
Study NCT05420480 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Two-Field lymph node dissection
Description: The right recurrent laryngeal nerve lymph node (106recR) will be dissected and subjected to the intra-operative frozen section pathology. If the 106recR lymph node has no metastasis, patients will be randomized to two groups at 1:1 ratio and receive esophagectomy with Two-Field or Three-Field lymph node dissection.
Study NCT05420480 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Three-Field lymph node dissection
Description: The right recurrent laryngeal nerve lymph node (106recR) will be dissected and subjected to the intra-operative frozen section pathology. If the 106recR lymph node has no metastasis, patients will be randomized to two groups at 1:1 ratio and receive esophagectomy with Two-Field or Three-Field lymph node dissection.
Study NCT05420480 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Three-Field lymph node dissection
Description: The right recurrent laryngeal nerve lymph node (106recR) will be dissected and subjected to the intra-operative frozen section pathology. If the 106recR lymph node has metastasis, esophagectomy and Three-Field lymph node dissection will be performed.
Study NCT05503394 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer support WeChat platform intervention
Description: Primary caregivers of children with biliary atresia are selected as the study population and divided into intervention and control groups in chronological order at a children's hospital in Shanghai. Primary caregivers who visit the hospital between August 2022 and October 2022 are assigned to the control group and primary caregivers who visit the hospital between January 2023 and March 2023 are assigned to the intervention group. The intervention group will receive a peer support WeChat platform intervention from the day of surgery to one month postoperatively. The level of negative emotions and caregiver burden will be compared between the two groups after the intervention. The intervention group receives the same routine care as the control group.
Study NCT05503394 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Routine nursing care group
Description: Provide routine inpatient education and post-discharge follow-up to primary caregivers of biliary atresia.
Study NCT05503394 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Routine nursing care group
Description: Provide routine inpatient education and post-discharge follow-up to primary caregivers of biliary atresia.
Study NCT06106178 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Simulator for Basic Ultrasound Skills
Description: Basic course of a traditional ultrasound simulator focusing on hand-eye coordination
Study NCT04710849 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serum metabolic markers
Description: Ultraperformance liquid chromatography / mass spectrometry (LC-MS) and gas chromatography / mass spectrometry (GC-MS) methods for analysis of the metabolites in AECOPD patients and compare the metabolites profiles between patients with systemic glucocorticoid treatment success and treatment failure.
Study NCT06322446 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 16-week exercise intervention: At the beginning of the intervention, we will conduct a face-to-face familiarisation session with the exercises of the training programme. The intervention will consist of 2 sessions/week for 16 weeks. Each session consists of three stages: (i) Warm-up: 10 min of joint mobility and low intensity exercises involving the musculature to be worked in that session; (ii) Main part: circuit training mainly composed of strength exercises targeting the different muscle groups of the body and playing activities (iii) Cool down: 10 min with guided breathing work and stretching of the main muscle groups worked
Study NCT06041152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: 2 macrodoses of 25mg separated by one week.
Study NCT06041152 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 doses of placebo separated by one week.
Study NCT05448508 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Automatic lancet
Description: An automatic lancet, which can reach a depth of 2.4 mm-3 mm, was used for safe piercing in babies.
Study NCT04730037 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Edoxaban
Description: - Edoxaban 30 mg/60 mg tablet according to body weight. 60 kg or less: 30 mg once daily, over 60 kg: 60 mg once daily, reduced to 30 mg once daily depending on renal function and concomitant medications
Study NCT04730037 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin Potassium
Description: - Warfarin K 1 mg tablets once daily (Dose adjusted with target PT-INR of 1.5-2.5)
Study NCT04730037 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin Potassium placebo
Description: - Warfarin K 1 mg placebo tablets once daily
Study NCT04730037 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Edoxaban placebo
Description: - Edoxaban 30 mg/60 mg placebo tablet according to body weight. 60 kg or less: 30 mg once daily, over 60 kg: 60 mg once daily, reduced to 30 mg once daily depending on renal function and concomitant medications
Study NCT05158036 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classic massage group
Description: Classic massage application will be given to the Classic massage group
Study NCT05158036 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Connective tissue masage
Description: Connective tissue masage application will be given to the Connective tissue masage group
Study NCT05261295 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PEEP
Description: PEEP of 7 cmH2O will be applied 5 minutes after classical LMA or i-gel insertion.
Study NCT06106178 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Serious Video Game
Description: The serious video game Underwater uses a 3D-printed ultrasound probe for maneuvering. During gameplay, coins must be collected in an underwater world using the aforementioned simulated ultrasound probe. The main focus of this game is to improve hand-eye coordination while using an ultrasound probe.
Study NCT05557981 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coaching
Description: A novel coaching curriculum based in positive psychology with an emphasis on self-reflection, goal setting and adverse event processing.
Study NCT05261295 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ZEEP
Description: PEEP of 0 cmH2O will be applied 5 minutes after classical LMA or i-gel insertion.
Study NCT05124262 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low- FODMAPdiet group intervention
Description: Diet intervention
Study NCT05076240 — intervention group
Intervention type: PROCEDURE
Intervention: FilmArray® analysis
Description: FilmArray® multiplex PCR analysis to diagnose ventilator associated pneumonia in COVID-19 ARDS
Study NCT05354973 — intervention group
Intervention type: DEVICE
Intervention: Consilium CareTM
Description: This is an observational study using the Consilium CareTM smartphone ePRO application.
Study NCT06293404 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: 7.5 mg Bupivacaine hydrochloride (0.5% heavy Marcaine) will be used on spinal anesthesia. (each group)
Study NCT05409092 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Astaxanthin
Description: 8 mg/day in one capsule for 4 weeks
Study NCT05409092 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 8 mg/day in one capsule for 4 weeks
Study NCT06402617 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation
Description: Standard clinical radio-frequency ablation isolation of pulmonary veins
Study NCT06402617 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Pulmonary vein isolation
Description: Standard clinical radio-frequency ablation isolation of pulmonary veins
Study NCT06402617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: RETRO-Mapping without adjunctive ablation
Description: RETRO-Mapping performed using research equipment and software, but without any adjunctive ablation
Study NCT06402617 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adjunctive ablation guided by RETRO-Mapping
Description: Radio-frequency ablation using a European conformity (CE)-marked ablation catheter of sites of focal activation identified by RETRO-Mapping
Study NCT05363514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Dose Naltrexone
Description: Participant takes Low Dose Naltrexone 4.5mg PO OD for 120 days. Participant will complete a a 4 week titration to target dose of 4.5mg. Week 1-2: 1.5mg PO OD. Week 3-4: 3.0mg PO OD. Week 5-16: 4.5mg PO OD. Participant will be provided with masked capsules in blister packs.
Study NCT05363514 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Microcrystalline cellulose
Description: Participant takes microcrystalline cellulose 4.5mg PO OD for 120 days. Participant will complete a a 4 week titration to target dose of 4.5mg. Week 1-2: 1.5mg PO OD. Week 3-4: 3.0mg PO OD. Week 5-16: 4.5mg PO OD. Participant will be provided with masked capsules in blister packs.
Study NCT05220943 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Video
Description: This 5-minute video presents clips with voiceover narration summarizing and highlighting the key safety points in the Center for Surgical Innovation (CSI) location.
Study NCT05498675 — intervention group
Intervention type: DRUG
Intervention: Sacubitril / Valsartan Oral Tablet [Entresto]
Description: There is no treatment allocation. Patients administered sacubitril / valsartan oral tablet (Entresto) 200mg 1/day by prescription that have started before inclusion of the patient enrolled into the study and defined as sacubitril/valsartan group.
Study NCT05498675 — intervention group
Intervention type: DRUG
Intervention: ACEI/ARB
Description: There is no treatment allocation. Patients administered angiotensin-converting enzyme inhibitors/angiotensin II receptor antagonists (ACEI/ARB) by prescription that have started before inclusion of the patient enrolled into the study and defined as ACEI/ARB group.~Including:~benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, trandolapril, azilsartan, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan.
Study NCT05569551 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Adhesive pouch
Description: Is a barrier dressing categorized under class C medical device. It is used to seal up the umbilical stump to prevent contamination until its cord detachment. It has an adhesive film that sticks to skin with a centrally located non-adhesive pouch ensuring that zero pressure is applied on the umbilicus. It is made of polyurethane, the same material as transparent intravenous cannula dressings making it hypoallergenic waterproof and breathable.
Study NCT04475783 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous Transluminal Angioplasty (PTA)
Description: PTA with an drug-coated balloon catheter (DCB) in the femoropopliteal artery
Study NCT04475783 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Percutaneous Transluminal Angioplasty (PTA)
Description: PTA with an drug-coated balloon catheter (DCB) in the femoropopliteal artery
Study NCT05262998 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Plate fixation
Description: Procedure: plate fixation~Plate fixation was performed by the regular on-call team surgeons and adhered to standard principles of fracture fixation. A standard surgical protocol was used, the approach was moved inferiorly, the fracture was reduced, sometimes with osteosutur and fixed with an antero-superior anatomical plate. 3.5mm Locked and cortical screws were used on both sides of the fracture. Fluoroscopy was used during the procedure. Intradermal suture was used to close the skin~Other: post-intervention All patients were discharged the day after the surgery. Interruption of work was given for 45 days. The same analgesics were administered in both groups for three weeks. Graduated exercises for the shoulder joint with pendular movements in a range of 15°-20° with the protection of a forearm sling were commenced from the postoperative second day. The sling was removed when X-ray films showed growth of callus or an indistinct fracture line.
Study NCT05262998 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intramedullary Screw
Description: Procedure: Intramedullary screw fixation~Intramedullary screw fixation was performed by the regular on-call team surgeons and adhered to standard principles of fracture fixation. Intramedullary screw fixation was performed by using a 1.6 or 2.8 mm-diameter threaded guide pin and a 85-100 mm long, 4.5 or 6.5 mm-diameter cannulated screw tapped in along the guide pin. Fluoroscopy was used during the procedure. Intradermal suture was used to close the skin.~Other: post-intervention All patients were discharged the day after the surgery. Interruption of work was given for 45 days. The same analgesics were administered in both groups for three weeks. Graduated exercises for the shoulder joint with pendular movements in a range of 15°-20° with the protection of a forearm sling were commenced from the postoperative second day. The sling was removed when X-ray films showed growth of callus or an indistinct fracture line.
Study NCT05631223 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telemedicine
Description: The intervention will consist of two structured telemedicine visits delivered between two routine office visits and conducted by providers (nurse practitioners and clinical nurse specialists).
Study NCT06232330 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group A
Description: This group will receive TOA which include Weight transfers from a standing position and stepping in various star-type directions, Sit-ups from different heights with the hemiplegic lower limb behind the normal lower limb, From a kneeling position alternately projecting the lower limb forward, From a standing position with a limited base of support turning head and trunk right to left, Continuous walking on a treadmill for 10 minutes, Ascending and descending of stairs, Crossing 4 obstacles with continuous walking, Walking while simultaneously pushing a stroller, Walking while holding an object, Walking on different surfaces and slopes, The intervention took place for 5 days a week for 6 week for 20 minutes. Pre measurement was taken before the intervention and after 6 weeks post measurement was taken.
Study NCT06232330 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group B
Description: This group will receive PNF techniques for trunk control. Rhythmic initiation and Rhythmic stabilization for a span of 20 minutes on both sides. In rhythmic initiation patient will move passively from trunk flexion into extension and then back to the flexed position When the patient is relaxed and moving easily, ask for active assisted motion Then begin resisting the motion then patient will perform independently in rhythmic stabilization Resist an isometric contraction of the patient's trunk flexor muscles patient will match the resistance in front and then in back
Study NCT04470687 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: contrast enhanced ultrafast ultrasound imaging
Description: Ultrasound contrast medium: SonoVue 8µL/mL (Bracco International BV) Ultrasound scanner: Aixplorer® device marketed by SuperSonic Imagine©, CE Doppler UltraFast™Doppler, contrast ultrasound (CEUS), color Doppler and ultra-sensitive energy Doppler, high-performance directional energy Doppler, Elastography ShearWave™ UF-Doppler (UltraFast-Doppler) and microbubble injection (SonoVue) Apparatus for performing the UF Doppler sequence: Aixplorer, manufacturer : Supersonic Imagine, Aix-en-Provence, France, CE Marking.~3D RCA dedicated vascular probe with dedicated Doppler sequences
Study NCT05346536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
Description: Detection of CTC-AXL(+) using 2 techniques:~* CellSearch®, FDA-USA approved technology~* EPIDROP System~CellSearch® (Menarini Company) The current gold-standard CellSearch® technique requires the use of CellSave tubes. This technique allows the isolation of fixed CTCs. This technique uses a positive (CellSearch® Epithelial Cell Kit) enrichment method from total blood using magnetic beads coupled to an EpCAM capture antibody. CTCs are then detected (anti-panCK antibodies, DAPI, anti-CD45 and characterized (anti-AXL antibody) by immunofluorescence (IF).~EPIDROP It requires the use of EDTA tubes. This technique is based on a method of negative enrichment of CTCs from total blood using a cocktail of tetrameric antibodies to eliminate unwanted blood cells and to preserve only purified tumor cells (RosetteSep - StemCell Technology).Then, cells are loaded in a microfluidic chip. The detection and characterization is done by IF to the single cell in micro-droplets.
Study NCT04892225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology-supported behavioral intervention (text message)
Description: A simple text message regarding the salt and fluid restriction in order to reduce the inter-dialytic weight gain will be send on daily basis to all the individuals in the intervention group.
Study NCT05326230 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paradise™ (PRDS-001) Renal Denervation Ultrasound System
Description: Following renal angiogram according to standard procedures, subjects remain blinded and are randomized to treatment with renal denervation or sham control
Study NCT05326230 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Renal Angiogram
Description: Following renal angiogram according to standard procedures, subjects remain blinded and renal angiogram is considered the sham procedure